Congrats to the CMR's @alastairsaunders.bsky.social (@pgregorevic.bsky.social Lab), for his new paper "Reduction of primary tumor growth and metastasis in models of triple-negative breast cancer following tilorone administration via type I interferon signaling" link.springer.com/article/10.1...
Reduction of primary tumor growth and metastasis in models of triple-negative breast cancer following tilorone administration via type I interferon signaling - Breast Cancer Research
Background People with triple-negative breast cancer (TNBC) typically have poorer survival than those with other breast cancer subtypes, with fewer treatment options available. Type I interferon (IFN)...
link.springer.com
